True. $8.6m annualised NPAT with 133m shares on issue implies 6.5c EPS and current run rate should be in excess of this. Hopefully cash flow improves and starts to reflect profit.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game